DNLAX
Price
$45.38
Change
-$0.15 (-0.33%)
Updated
Oct 7 closing price
Net Assets
998.22M
PRNEX
Price
$43.02
Change
-$0.01 (-0.02%)
Updated
Oct 7 closing price
Net Assets
2.48B
Interact to see
Advertisement

DNLAX vs PRNEX

Header iconDNLAX vs PRNEX Comparison
Open Charts DNLAX vs PRNEXBanner chart's image
BNY Mellon Natural Resources A
Price$45.38
Change-$0.15 (-0.33%)
VolumeN/A
Net Assets998.22M
T. Rowe Price New Era
Price$43.02
Change-$0.01 (-0.02%)
VolumeN/A
Net Assets2.48B
DNLAX vs PRNEX Comparison Chart in %
View a ticker or compare two or three
VS
DNLAX vs. PRNEX commentary
Oct 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DNLAX is a Buy and PRNEX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
PRNEX has more cash in the bank: 2.48B vs. DNLAX (998M). PRNEX pays higher dividends than DNLAX: PRNEX (1.81) vs DNLAX (1.10). DNLAX was incepted earlier than PRNEX: DNLAX (22 years) vs PRNEX (57 years). DNLAX (1.16) is less costly to investors than PRNEX (0.77). DNLAX is a more actively managed with annual turnover of: 103.94 vs. PRNEX (24.30). DNLAX has a lower initial minimum investment than PRNEX: DNLAX (1000) vs PRNEX (2500). PRNEX annual gain was more profitable for investors over the last year : 4.04 vs. DNLAX (-7.57). DNLAX return over 5 years is better than : 76.99 vs. PRNEX (65.83).
DNLAXPRNEXDNLAX / PRNEX
Total Expense Ratio1.160.77151%
Annual Report Gross Expense Ratio1.160.77151%
Fund Existence22 years57 years-
Gain YTD8.22415.79752%
Front Load6%N/A-
Min. Initial Investment1000250040%
Min. Initial Investment IRAN/AN/A-
Net Assets998M2.48B40%
Annual Yield % from dividends1.101.8160%
Returns for 1 year-7.574.04-187%
Returns for 3 years-11.7219.63-60%
Returns for 5 years76.9965.83117%
Returns for 10 years86.5963.87136%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
SDMGX22.60N/A
N/A
Sit Developing Markets Growth
SHSSX67.81N/A
N/A
BlackRock Health Sciences Opps Instl
RLCAX9.33N/A
N/A
Columbia Disciplined Value A
QQMNX20.93N/A
N/A
Federated Hermes MDT Market Neutral IS
FCUEX20.59-0.15
-0.72%
NYLI PineStone U.S. Equity Class A